TSLA
Tesla
-- 424.070 NVDA
NVIDIA
-- 140.830 AAPL
Apple
-- 222.640 TEM
Tempus AI
-- 47.640 NFLX
Netflix
-- 869.680 
Sirio Pharma's P/E ratio is typical for moderate growth expe...
Sirio Pharma's P/E ratio is typical for moderate growth expectations, but its superior earnings outlook isn't impacting its P/E as expected, indicating potential unseen threats to earnings. Investors anticipate future earnings volatility.
Take Care Before Diving Into The Deep End On Sirio Pharma Co., Ltd. (SZSE:300791)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
4734
Followers
0
Following
10K
Visitors
Follow
Discussing
Trump 2.0 Era: What's the next opportunity in the markets?
▪️Could Trump's crypto policies potentially benefit the crypto market? ▪️Might his tariff policies have a positive effect on Chinese stocks
Michael McCarthy CCO
Jan 3 11:57
Ask a strategist - Trump's first day